ANGLE plc (ANPCF)
USD 0.31
(92.55%)
USD 0.31
(92.55%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -20.13 Million GBP | 7.17% |
| 2022 | -21.68 Million GBP | -44.46% |
| 2021 | -15.01 Million GBP | -29.35% |
| 2020 | -11.6 Million GBP | -2.4% |
| 2019 | -11.33 Million GBP | -26.75% |
| 2018 | -8.94 Million GBP | -18.34% |
| 2017 | -7.55 Million GBP | -15.06% |
| 2016 | -6.56 Million GBP | -34.21% |
| 2015 | -4.89 Million GBP | -36.14% |
| 2014 | -3.59 Million GBP | -237.78% |
| 2013 | -1.06 Million GBP | -22.9% |
| 2012 | -865.73 Thousand GBP | 66.51% |
| 2011 | -2.58 Million GBP | -630.23% |
| 2010 | -354 Thousand GBP | -704.55% |
| 2009 | -44 Thousand GBP | 98.78% |
| 2008 | -3.59 Million GBP | -397.11% |
| 2007 | 1.21 Million GBP | 113.29% |
| 2006 | -9.1 Million GBP | -260.57% |
| 2005 | -2.52 Million GBP | 0.0% |
| 2004 | -2.52 Million GBP | -210.26% |
| 2003 | 2.29 Million GBP | 750.85% |
| 2002 | -352 Thousand GBP | 62.99% |
| 2001 | -951 Thousand GBP | 28.28% |
| 2000 | -1.32 Million GBP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.85 Million GBP | 25.25% |
| 2024 Q2 | -3.85 Million GBP | 0.0% |
| 2023 Q1 | -4.9 Million GBP | 60.64% |
| 2023 Q3 | -5.15 Million GBP | 47.42% |
| 2023 Q4 | -5.15 Million GBP | 0.0% |
| 2023 FY | -20.13 Million GBP | 7.17% |
| 2023 Q2 | -9.81 Million GBP | -100.0% |
| 2022 Q4 | -12.46 Million GBP | -100.0% |
| 2022 Q2 | -9.22 Million GBP | -100.0% |
| 2022 Q1 | -4.61 Million GBP | 37.09% |
| 2022 FY | -21.68 Million GBP | -44.46% |
| 2022 Q3 | -6.23 Million GBP | 32.41% |
| 2021 Q1 | -3.84 Million GBP | 43.86% |
| 2021 Q4 | -7.32 Million GBP | -100.0% |
| 2021 Q2 | -7.68 Million GBP | -100.0% |
| 2021 FY | -15.01 Million GBP | -29.35% |
| 2021 Q3 | -3.66 Million GBP | 52.3% |
| 2020 Q2 | -4.76 Million GBP | -180.26% |
| 2020 Q1 | -1.69 Million GBP | 0.0% |
| 2020 FY | -11.6 Million GBP | -2.4% |
| 2020 Q3 | -4.1 Million GBP | 13.85% |
| 2020 Q4 | -6.84 Million GBP | -66.76% |
| 2019 Q1 | -2.34 Million GBP | 0.0% |
| 2019 FY | -11.33 Million GBP | -26.75% |
| 2019 Q2 | -2.42 Million GBP | -3.48% |
| 2018 Q3 | -4.25 Million GBP | 0.0% |
| 2018 Q1 | -4.11 Million GBP | -100.0% |
| 2018 Q4 | -2.34 Million GBP | 45.0% |
| 2018 FY | -8.94 Million GBP | -18.34% |
| 2017 Q2 | -1.71 Million GBP | 0.0% |
| 2017 Q4 | -2.05 Million GBP | -19.78% |
| 2017 Q3 | -1.71 Million GBP | 0.0% |
| 2017 FY | -7.55 Million GBP | -15.06% |
| 2016 Q1 | -1.36 Million GBP | 0.0% |
| 2016 Q3 | -1.29 Million GBP | 0.0% |
| 2016 Q2 | -1.29 Million GBP | 5.01% |
| 2016 FY | -6.56 Million GBP | -34.21% |
| 2015 FY | -4.89 Million GBP | -36.14% |
| 2015 Q1 | -1.06 Million GBP | 0.0% |
| 2015 Q2 | -1.09 Million GBP | -2.53% |
| 2015 Q3 | -1.09 Million GBP | 0.0% |
| 2015 Q4 | -1.36 Million GBP | -24.94% |
| 2014 Q1 | -1.29 Million GBP | -287.72% |
| 2014 Q4 | -1.06 Million GBP | -48.16% |
| 2014 Q3 | -720.5 Thousand GBP | 0.0% |
| 2014 FY | -3.59 Million GBP | -237.78% |
| 2014 Q2 | -720.5 Thousand GBP | 44.36% |
| 2013 Q2 | -198 Thousand GBP | 33.67% |
| 2013 Q3 | -198 Thousand GBP | 0.0% |
| 2013 FY | -1.06 Million GBP | -22.9% |
| 2013 Q1 | -298.5 Thousand GBP | 0.0% |
| 2013 Q4 | -334 Thousand GBP | -68.69% |
| 2012 Q4 | -298.5 Thousand GBP | -121.93% |
| 2012 FY | -865.73 Thousand GBP | 66.51% |
| 2012 Q2 | -134.5 Thousand GBP | 0.0% |
| 2012 Q3 | -134.5 Thousand GBP | 0.0% |
| 2011 FY | -2.58 Million GBP | -630.23% |
| 2010 FY | -354 Thousand GBP | -704.55% |
| 2009 FY | -44 Thousand GBP | 98.78% |
| 2008 FY | -3.59 Million GBP | -397.11% |
| 2007 FY | 1.21 Million GBP | 113.29% |
| 2006 FY | -9.1 Million GBP | -260.57% |
| 2005 FY | -2.52 Million GBP | 0.0% |
| 2004 FY | -2.52 Million GBP | -210.26% |
| 2003 FY | 2.29 Million GBP | 750.85% |
| 2002 FY | -352 Thousand GBP | 62.99% |
| 2001 FY | -951 Thousand GBP | 28.28% |
| 2000 FY | -1.32 Million GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -1327.801% |
| Arrayit Corporation | -3.31 Million USD | -507.191% |
| Atlantic International Corp. | -5.62 Million USD | -257.737% |
| Biocept, Inc. | -32.08 Million USD | 37.258% |
| Bioqual, Inc. | 483.48 Thousand USD | 4263.969% |
| CardioGenics Holdings Inc | -1.91 Million USD | -950.553% |
| DermTech, Inc. | -100.88 Million USD | 80.045% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.994% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 6.772% |
| iMD Companies, Inc. | -200.63 Thousand USD | -9934.092% |
| IDenta Corp. | 14.64 Thousand USD | 137576.099% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 2610.224% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 52135.462% |
| InVitro International | 1553.00 USD | 1296429.684% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | -134.311% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -34543.447% |
| Medical Imaging Corp. | -3.02 Million USD | -565.956% |
| NovelStem International Corp. | -4.18 Million USD | -380.787% |
| Optigenex Inc. | -2.89 Million USD | -594.744% |
| PharmChem, Inc. | 845.1 Thousand USD | 2482.198% |
| Proteome Sciences plc | -2.44 Million USD | -724.069% |
| Response Genetics, Inc | -20.18 Million USD | 0.258% |
| Rennova Health, Inc. | -3.29 Million USD | -511.347% |
| RushNet, Inc. | -607.02 Thousand USD | -3216.486% |
| ScreenPro Security Inc. | -2.24 Million USD | -795.246% |
| Stella Diagnostics Inc. | -5.7 Million USD | -252.733% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | -76.359% |
| Todos Medical Ltd. | -24.99 Million USD | 19.453% |